Magenta Therapeutics IncNASDAQ:MGTA
- LAST PRICE0.5622
- TODAY'S CHANGE (%)0.0153 (2.7976%)
- Bid / Lots0.5601/ 5
- Ask / Lots0.5643/ 1
- Open / Previous Close0.5550 / 0.5469
- Day Range
- 52 Week Range
- Volume255,392
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGTA |
|---|---|---|
| 09:32 ET | 2374 | 0.5549 |
| 09:33 ET | 15333 | 0.55 |
| 09:35 ET | 9050 | 0.54 |
| 09:37 ET | 7122 | 0.5587 |
| 09:39 ET | 11100 | 0.53 |
| 09:42 ET | 100 | 0.53 |
| 09:46 ET | 1100 | 0.53 |
| 09:51 ET | 267 | 0.541 |
| 09:53 ET | 7070 | 0.555 |
| 09:55 ET | 935 | 0.569999 |
| 09:57 ET | 200 | 0.5546 |
| 10:00 ET | 14713 | 0.56 |
| 10:02 ET | 200 | 0.555 |
| 10:04 ET | 139 | 0.5443 |
| 10:06 ET | 599 | 0.555 |
| 10:08 ET | 11848 | 0.555 |
| 10:11 ET | 100 | 0.569799 |
| 10:13 ET | 100 | 0.555 |
| 10:15 ET | 6000 | 0.5692 |
| 10:18 ET | 4980 | 0.56 |
| 10:20 ET | 100 | 0.56 |
| 10:24 ET | 2620 | 0.5605 |
| 10:26 ET | 300 | 0.56 |
| 10:27 ET | 14401 | 0.57 |
| 10:29 ET | 2265 | 0.57 |
| 10:31 ET | 100 | 0.56 |
| 10:33 ET | 24333 | 0.5601 |
| 10:42 ET | 600 | 0.565 |
| 10:47 ET | 1078 | 0.5603 |
| 10:49 ET | 950 | 0.5602 |
| 10:51 ET | 200 | 0.5644 |
| 10:54 ET | 300 | 0.5685 |
| 10:56 ET | 100 | 0.5685 |
| 10:58 ET | 200 | 0.5664 |
| 11:00 ET | 200 | 0.5601 |
| 11:03 ET | 800 | 0.5664 |
| 11:05 ET | 1100 | 0.5601 |
| 11:07 ET | 200 | 0.5601 |
| 11:09 ET | 318 | 0.5601 |
| 11:12 ET | 100 | 0.5601 |
| 11:14 ET | 510 | 0.5601 |
| 11:16 ET | 600 | 0.5624 |
| 11:18 ET | 1105 | 0.56 |
| 11:21 ET | 740 | 0.5664 |
| 11:23 ET | 2855 | 0.5583 |
| 11:25 ET | 200 | 0.5664 |
| 11:34 ET | 760 | 0.5664 |
| 11:41 ET | 100 | 0.56 |
| 11:43 ET | 22000 | 0.56 |
| 11:45 ET | 300 | 0.56 |
| 11:50 ET | 500 | 0.56 |
| 11:54 ET | 11200 | 0.5623 |
| 11:56 ET | 100 | 0.56 |
| 11:59 ET | 422 | 0.56 |
| 12:01 ET | 425 | 0.5584 |
| 12:03 ET | 300 | 0.56 |
| 12:10 ET | 700 | 0.5623 |
| 12:14 ET | 100 | 0.56 |
| 12:17 ET | 100 | 0.5663 |
| 12:19 ET | 100 | 0.56 |
| 12:21 ET | 300 | 0.5663 |
| 12:26 ET | 100 | 0.5663 |
| 12:28 ET | 100 | 0.5663 |
| 12:32 ET | 200 | 0.5663 |
| 12:35 ET | 23982 | 0.5714 |
| 12:37 ET | 600 | 0.5733 |
| 12:39 ET | 100 | 0.5742 |
| 12:42 ET | 3200 | 0.5752 |
| 12:44 ET | 3000 | 0.5763 |
| 12:46 ET | 200 | 0.5779 |
| 12:50 ET | 200 | 0.5779 |
| 12:51 ET | 200 | 0.5779 |
| 12:53 ET | 3285 | 0.5696 |
| 01:02 ET | 600 | 0.565 |
| 01:06 ET | 900 | 0.565 |
| 01:08 ET | 4100 | 0.5734 |
| 01:09 ET | 200 | 0.5734 |
| 01:11 ET | 600 | 0.5733 |
| 01:13 ET | 3641 | 0.5643 |
| 01:15 ET | 100 | 0.5643 |
| 01:18 ET | 2512 | 0.5632 |
| 01:22 ET | 662 | 0.5601 |
| 01:24 ET | 3400 | 0.5601 |
| 01:27 ET | 1200 | 0.5643 |
| 01:33 ET | 130 | 0.560101 |
| 01:36 ET | 1100 | 0.5643 |
| 01:40 ET | 200 | 0.5622 |
Jan 26, 2023
--BTIG Downgrades Magenta Therapeutics to Neutral From Buy, from 12:07PM ET on Thursday Jan 26, 2023 by MT Newswires
12:07PM ET on Thursday Jan 26, 2023 by MT Newswires--Cowen Downgrades Magenta Therapeutics to Market Perform From Outperform, from 9:59AM ET on Thursday Jan 26, 2023 by MT Newswires
9:59AM ET on Thursday Jan 26, 2023 by MT NewswiresTop Premarket Decliners, from 8:06AM ET on Thursday Jan 26, 2023 by MT Newswires
8:06AM ET on Thursday Jan 26, 2023 by MT NewswiresWedbush Downgrades Magenta Therapeutics to Neutral From Outperform on MGTA-117 Safety Issues, Lowers Price Targe to $1 From $3, from 7:47AM ET on Thursday Jan 26, 2023 by MT Newswires
7:47AM ET on Thursday Jan 26, 2023 by MT Newswires
Jan 25, 2023
BRIEF-Magenta Therapeutics Voluntarily Pauses Blood Cancer Therapy Trial To Investigate Drug Safety, from 5:23PM ET on Wednesday Jan 25, 2023 by Thomson Reuters
5:23PM ET on Wednesday Jan 25, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Magenta Therapeutics Inc | 33.1M | -0.4x | --- |
Better Therapeutics Inc | 32.5M | -0.5x | --- |
PaxMedica Inc | 32.5M | -9.3x | --- |
Alterola Biotech Inc | 32.3M | -7.6x | --- |
TFF Pharmaceuticals Inc | 33.7M | -0.7x | --- |
Vincerx Pharma Inc | 32.0M | -0.5x | --- |
Company Information
Magenta Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases and autoimmune diseases. Its drug development pipeline includes multiple product candidates designed to improve stem cell transplants. Its lead clinical program is designed to mobilize and collect sufficient functional stem cells for use in stem cell transplantation, a process known as mobilization. It is also developing product candidates that are designed to deplete targeted cells in the bone marrow to make space for the bone marrow to receive newly transplanted stem cells, a process known as conditioning. The Company's pipeline of stem cell transplant product candidates consists of MGTA-145, MGTA-117, C300, C100, G100, MGTA-456 and E478. It is developing product candidates to be used individually or, in some cases, in combination with each other.
Contact Information
- Headquarters
- 100 Technology Sq Fl 5CAMBRIDGE, MA, United States 02139-3585
- Phone
- 857-201-2700
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Alison Lawton
- President, Chief Executive Officer, Co-Founder, Director
- Jason Gardner
- Chief Financial and Operating Officer, Treasurer
- Stephen Mahoney
- Chief People Officer
- Kristen Stants
- Chief Technical Officer
- David Nichols
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 60.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.19 |
EPS | $-1.28 |
Book Value | $2.94 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
